MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$15,603K
Net Income
-$23,527K
Net Profit Margin
-150.79%
EPS
-$6.62
Unit: Thousand (K) dollars
Revenue Breakdown
Product
License And Collaboration
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Total revenue
15,603
10,906
-5,423*
7,406
Cost of goods sold
3,610
1,673
-2,960*
2,316
Selling, general and administrative
27,673
21,104
2,321*
19,628
Research and development
600
186
238*
145
Amortization of intangible assets
1,043
1,031
-481*
679
Total operating expenses
32,926
23,994
-882*
22,768
Operating loss
-17,323
-13,088
-4,541*
-15,362
Interest expense
2,389
2,353
753*
-
Impairment of intangible assets
-
-
71*
-
Interest expense
-
-
-
1,346
Change in fair value of convertible debt
-3,705
-9,632
-15,103*
-
Interest income and other income
-
-
-10*
5
Total other expense
-6,094
-11,985
-15,937*
-1,341
Net loss before provision for income taxes
-23,417
-25,073
-20,478*
-16,703
Provision for income taxes
0
0
-6,689*
-465
Net loss
-23,417
-25,073
-13,789
-
Change in fair value of convertible debt due to instrument credit risk
-110
2,188
-
-
Net loss and comprehensive loss
-
-
-
-16,238
Comprehensive loss
-23,527
-22,885
-
-
Basic EPS
-6.62
-7.57
-7.332
-5.3
Diluted EPS
-6.62
-7.57
-7.332
-5.3
Basic Average Shares
3,539,464
3,311,742
1,880,498*
3,061,488
Diluted Average Shares
3,539,464
3,311,742
1,880,498*
3,061,488
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Comprehensive loss
-$23,527K
Net loss
-$23,417K
(-578.96%↓ Y/Y)
Change in fair value of
convertible debt due to...
-$110K
Net loss before
provision for income taxes
-$23,417K
(-578.96%↓ Y/Y)
Product
$15,420K
License And
Collaboration
$183K
Operating loss
-$17,323K
(-436.25%↓ Y/Y)
Total other expense
-$6,094K
(-2688.81%↓ Y/Y)
Total revenue
$15,603K
Total operating
expenses
$32,926K
(919.25%↑ Y/Y)
Change in fair value of
convertible debt
-$3,705K
Interest expense
$2,389K
(993.28%↑ Y/Y)
Selling, general and
administrative
$27,673K
Cost of goods sold
$3,610K
Amortization of intangible
assets
$1,043K
Research and development
$600K
(16.55%↑ Y/Y)
Buy us a coffee
Pelthos Therapeutics Inc. (PTHS)
Pelthos Therapeutics Inc. (PTHS)